- Home
- SMTI vs MTLS Comparison
SMTI vs MTLS Comparison
Compare SMTI & MTLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SMTI
- MTLS
- Stock Information
- Founded
- SMTI 1982
- MTLS 1990
- Country
- SMTI United States
- MTLS Belgium
- Employees
- SMTI N/A
- MTLS N/A
- Industry
- SMTI Medical/Dental Instruments
- MTLS Computer Software: Prepackaged Software
- Sector
- SMTI Health Care
- MTLS Technology
- Exchange
- SMTI Nasdaq
- MTLS Nasdaq
- Market Cap
- SMTI 297.2M
- MTLS 297.1M
- IPO Year
- SMTI N/A
- MTLS 2014
- Fundamental
- Price
- SMTI $29.58
- MTLS $5.16
- Analyst Decision
- SMTI Strong Buy
- MTLS Buy
- Analyst Count
- SMTI 2
- MTLS 1
- Target Price
- SMTI $48.50
- MTLS $9.50
- AVG Volume (30 Days)
- SMTI 24.5K
- MTLS 239.5K
- Earning Date
- SMTI 03-25-2025
- MTLS 04-24-2025
- Dividend Yield
- SMTI N/A
- MTLS N/A
- EPS Growth
- SMTI N/A
- MTLS 106.79
- EPS
- SMTI N/A
- MTLS 0.24
- Revenue
- SMTI $86,672,425.00
- MTLS $276,182,835.00
- Revenue This Year
- SMTI $22.51
- MTLS $6.55
- Revenue Next Year
- SMTI $8.17
- MTLS $9.21
- P/E Ratio
- SMTI N/A
- MTLS $21.95
- Revenue Growth
- SMTI 33.36
- MTLS 4.15
- 52 Week Low
- SMTI $26.00
- MTLS $4.70
- 52 Week High
- SMTI $39.08
- MTLS $9.69
- Technical
- Relative Strength Index (RSI)
- SMTI 42.00
- MTLS 37.42
- Support Level
- SMTI $32.59
- MTLS $5.01
- Resistance Level
- SMTI $35.69
- MTLS $5.46
- Average True Range (ATR)
- SMTI 1.50
- MTLS 0.18
- MACD
- SMTI 0.14
- MTLS 0.12
- Stochastic Oscillator
- SMTI 17.46
- MTLS 59.32
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are HYCOL Hydrolyzed Collagen, BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
About MTLS Materialise NV
Materialise NV is a provider of 3D printing services. The products and services of the group are organized in three segments: Medical segment, which develops and delivers medical software solutions, medical devices, and other related products and services; Software segment, which develops and delivers additive manufacturing software solutions and related services; and Manufacturing segment, which delivers 3D printed products and related services. Its geographical segments are the United States, the Americas (excluding the USA), Belgium, Germany, Poland, France, Switzerland, the United Kingdom, Italy, the Netherlands, Other Europe, and the Asia Pacific.